|
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma
RECRUITINGSponsored by Shanghai University of Traditional Chinese Medicine
Actively Recruiting
SponsorShanghai University of Traditional Chinese Medicine
Started2022-11-01
Est. completion2026-08
Eligibility
Age14 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05496582
Summary
Asthma is one of the most common chronic respiratory diseases. Previous study found a series of differentially expressed genes and proteins (transgelin-2, metallothionein-2, ezrin) in asthmatic rat. The aim of the study is to investigate the changes and associations of these gene with asthma in human.
Eligibility
Age: 14 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Males or females, aged 14-75 years; 2. Patients with a definite diagnosis of bronchial asthma; 3. The diagnosis of asthma according to the Global Initiative for Asthma (GINA), with positive bronchodilator responsiveness (reversibility) test; 4. Healthy volunteers without respiratory symptoms such as cough, wheezing, chest tightness or dyspnea; 5. Agree with all procedures in this trial by signing a written informed consent form. Exclusion Criteria: 1. Patients with chronic obstructive pulmonary disease or other airway disease; 2. Complicated with other severe primary diseases (including hypertension, cancer, hyperthyroidism, bronchiectasia, cardiac insufficiency) and conditions that would prevent participation in the trial or put the participant at risk; 3. Women who are known to be pregnant or breastfeeding; 4. Not willing to participate; 5. Psychiatric history and neurological disorders can not work normally; 6. Other conditions that the researcher considers inappropriate to participate in this study.
Conditions1
Asthma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorShanghai University of Traditional Chinese Medicine
Started2022-11-01
Est. completion2026-08
Eligibility
Age14 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05496582